On the 19th of August, the WHO Essential Medicines and Health Products (EMP) Department released a Medical Product Alert describing falsified oral quinine antimalarials circulating in West Africa. When taken by patients with falciparum malaria they will lead to poor patient outcomes and potentially death. Quinine Sulfate 300 mg with stated manufacturer ‘Novadina Pharmaceutical Ltd’ in Cameroon and Quinine Sulphate 300 mg labelled as made by ‘CAD Pharm’ in Buni (Democratic Republic of Congo) failed the initial screening tests and analysis showed that neither product contained any of the stated active pharmaceutical ingredient.
The full WHO rapid alert is available in English at:
(Visited 10 times, 1 visits today)